A detailed history of New Century Financial Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, New Century Financial Group, LLC holds 8,395 shares of ABBV stock, worth $1.69 Million. This represents 0.61% of its overall portfolio holdings.

Number of Shares
8,395
Previous 7,705 8.96%
Holding current value
$1.69 Million
Previous $1.32 Billion 25.43%
% of portfolio
0.61%
Previous 0.56%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 18, 2024

BUY
$163.84 - $199.33 $113,049 - $137,537
690 Added 8.96%
8,395 $1.66 Billion
Q2 2024

Aug 27, 2024

BUY
$154.79 - $180.76 $923,167 - $1.08 Million
5,964 Added 342.56%
7,705 $1.32 Billion
Q1 2024

Apr 19, 2024

BUY
$159.82 - $182.1 $3,516 - $4,006
22 Added 1.28%
1,741 $317 Million
Q4 2023

Feb 08, 2024

BUY
$137.6 - $154.97 $236,534 - $266,393
1,719 New
1,719 $266 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $357B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track New Century Financial Group, LLC Portfolio

Follow New Century Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of New Century Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on New Century Financial Group, LLC with notifications on news.